Children's Healthcare of Atlanta
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Children's Healthcare of Atlanta sits in the top decile of US sponsors by registered trial count (#280 of 15,742 sponsors by registered trial count).
Children's Healthcare of Atlanta: 80 sponsored US clinical trials, 2 recruiting.
Children's Healthcare of Atlanta sponsors 80 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 29 completed. 2 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Congenital Disorders, with 3 trials.
Top-decile sponsor footprint
Children's Healthcare of Atlanta ranks in the top decile of sponsors by registered trial count (#280 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
29 of 77 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (37.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
80 total, page 2 of 2
Comparison of NIRS and Serum Lactate to Predict Poor Post-operative Outcomes
NCT00485524
Neonates With Neurological Complications
NCT00366561
Retrospective Review of the Outcomes of Newborns With Genetic Abnormalities
NCT00366821
Biventricular Pacing in the Pediatric Population
NCT00267423
Incidence of Neo-Aortic Insufficiency
NCT00268073
Computer Modeling of Congenital Heart Disease
NCT00366847
Re-operative Surgery in Children:A Technique for Sternal Re-Entry
NCT00328146
Hypoxemia in Infants After Palliative Surgery
NCT00327977
Infant Weight Gain With Trisomy 21 and CAVC
NCT00327951
Growth in Children With HLHS
NCT00277992
Outcomes of Children With Congenital Single Ventricle Heart
NCT00266968
Retrospective of Children With ADHD and Cardiac Symptoms
NCT00266955
Automated Cardioverter Defibrillator in Children
NCT00268021
Infection in DiGeorge Following CHD Surgery
NCT00278005
Eisenmenger's Syndrome in Adults With CHD
NCT00266903
Hypertrophic Myopathy in Children
NCT00267462
Percutaneous Interventions in Adults With CHD
NCT00266916
Palliative Care of Children With End-Stage Heart Failure
NCT00327782
Ross Aortic Valve Replacement Patients
NCT00267995
Radiofrequency Ablation of Ectopic Atrial Tachycardia
NCT00267982
Intra-Atrial vs. Extra-Cardiac Technique During Fontan Operation
NCT00266942
Racial Distribution of Heterotaxy Syndrome
NCT00485654
Mild Valvar Pulmonary Stenosis
NCT00277927
Children and Adolescents Receiving Mechanical and Prosthetic Valves
NCT00268008
Prevalence and Clinical Spectrum of the 22q11 Deletion
NCT00267397
Aortic Arch Reconstruction
NCT00277940
Patients With NMDA Biomarker Data Following Cardiac Surgery
NCT00366886
MRI Review of Tracheal Dimensions
NCT00277953
Constrictive Pericarditis in the Adult Congenital Cardiac Population
NCT00268086
Pulmonary Resistance in Fontan Who Have Undergone Heart Transplantation
NCT00268047
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Therapeutic Areas
Where Children's Healthcare of Atlanta enrollment is open (later-stage tilt)
2 recruiting of 80 indexed (3% open); 29 completed (36%).
Phase mix: 2 late (III/IV) vs 1 early (I/II) (later-stage heavy).
Top condition: Congenital Disorders (3 trials), 8 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Children's Healthcare of Atlanta: open-pipeline peers nationwide
Peers matched on 80 registered trials and 3% open enrollment, not the therapeutic-area sidebar.
Children's Healthcare of Atlanta sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 80 trials (± recruiting share)
- BioMarin Pharmaceutical · 80 trials · 16% recruiting
- EMD Serono Research & Development Institute · 81 trials · 11% recruiting
- The University of Tennessee, Knoxville · 81 trials · 7% recruiting
- TriHealth · 81 trials · 2% recruiting
Sponsors near 3% open enrollment (± trial volume)
- Harvard School of Public Health (HSPH) · 3% recruiting · 40 trials
- Ethicon Endo-Surgery · 3% recruiting · 39 trials
- Cumberland Pharmaceuticals · 2% recruiting · 43 trials
- Appalachian State University · 3% recruiting · 37 trials
Related
What to do with this Children's Healthcare of Atlanta page
80 registered trials is a research-attention snapshot, not an endorsement of Children's Healthcare of Atlanta or any single study.
- 2 of Children's Healthcare of Atlanta's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Congenital Disorders is the condition Children's Healthcare of Atlanta studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Congenital Disorders trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Children's Healthcare of Atlanta pipeline card: 80 registered trials from official public datasets.Report a data error.